REQUEST A DEMO
Total
USD $0.00
Search more companies

Comercializadora Medipluss Ltda (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Comercializadora Medipluss Ltda Profile Updated: January 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Comercializadora Medipluss Ltda is based in Colombia, with the head office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on August 25, 2008. It currently has a total number of 2 (2025) employees. In 2024, the company reported a net sales revenue drop of 19.9%. During that time, Comercializadora Medipluss Ltda’s total assets grew by 1.91%. The enterprise’s net profit margin increased by 1.54% in 2024.

Headquarters
Cr 7 # 29 34 Of 204
Bogota D.C.; Bogota D.C; Postal Code: 0112

Contact Details: Purchase the Comercializadora Medipluss Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Comercializadora Medipluss Ltda report to view the information.
Financial Auditors:
Purchase the Comercializadora Medipluss Ltda report to view the information.
Incorporation Date:
August 25, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Comercializadora Medipluss Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-19.9%
Total Operating Revenue
-19.9%
Operating Profit
562.82%
Net Profit/Loss for the Period
58.18%
Total Assets
1.91%
Total Equity
3.55%
Operating Profit Margin
2.98%
Net Profit Margin
1.54%
Return on Equity (ROE)
1.46%
Quick Ratio
716.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?